Back
10-Q2025-07-24· deepseek-v4-flash

INTC · Intel Corporation

0000050863-25-000109

SEC filing

Summary

Intel posted a net loss of $2.9B in Q2 2025, weighed down by $1.9B in restructuring and $797M in manufacturing asset impairments, as revenue held flat at $12.9B.

Key takeaways

Full analysis

Period Performance

Intel's second quarter of fiscal 2025 was characterized by a significant net loss driven by restructuring and impairment charges, while revenue remained essentially flat year-over-year. For the quarter ended June 28, 2025, total net revenue was $12.86 billion, compared to $12.83 billion in the same quarter last year, reflecting a 0% change. Gross profit fell 22% to $3.54 billion, resulting in a gross margin of 27.5% versus 35.4% a year ago. The decline was primarily attributed to $797 million in non-cash manufacturing asset impairment and accelerated depreciation charges recorded in cost of sales within the Intel Foundry segment, along with higher inventory reserves for Gaudi AI accelerators ($209 million in one-time period costs and $361 million year-to-date).

Operating loss widened to $3.18 billion from $1.96 billion, driven by $1.89 billion in restructuring and other charges (including $1.47 billion in employee severance from the 2025 Restructuring Plan) and the aforementioned asset impairments. Net loss attributable to Intel was $2.92 billion, or ($0.67) per diluted share, compared to a net loss of $1.61 billion, or ($0.38) per share, in the prior year period. The effective tax rate was negative 9.2% versus a positive 17.5% a year ago, largely due to the inability to benefit current period losses because of a domestic valuation allowance established in Q3 2024.

Segment Performance: Client Computing Group (CCG) revenue declined 3% to $7.87 billion, driven by lower client volume as incremental purchasing incentives offered to certain customers in the prior year were reduced. Operating income decreased to $2.05 billion from $2.64 billion, with operating margin compressing from 32% to 26%. Data Center and AI (DCAI) revenue grew 4% to $3.94 billion, supported by higher hyperscale customer-related demand (server volume up 13%), though server ASPs fell 8% due to competitive pricing. DCAI operating income increased to $633 million from $242 million, benefiting from lower operating expenses from headcount reductions. Intel Foundry revenue increased 3% to $4.42 billion, but its operating loss deepened to $3.17 billion from $2.80 billion, reflecting the $797 million in manufacturing asset impairment charges. The All Other segment saw revenue grow 20% to $1.05 billion, with operating income turning positive at $69 million, driven by higher Altera and Mobileye demand.

Balance Sheet & Liquidity

As of June 28, 2025, Intel held $21.2 billion in cash and short-term investments, down from $22.1 billion at December 28, 2024. Total debt increased slightly to $50.8 billion from $50.0 billion, reflecting $2.0 billion in commercial paper outstanding (4.60%) at quarter-end, partially offset by $1.5 billion in long-term debt repayments. Stockholders' equity declined to $105.8 billion from $105.0 billion, as the net loss and partner distributions outpaced partner contributions and other comprehensive income gains. The company had $7.2 billion remaining under its share repurchase authorization, but no shares were repurchased during the quarter. No dividends were paid in the first half of 2025, compared to $1.1 billion in the prior year period.

Government incentives provided a significant cash inflow: $964 million in proceeds from capital-related government incentives during the first six months of 2025, and recognition of $890 million in CHIPS Act grants (including $742 million reducing property, plant, and equipment). Additionally, $759 million in advanced manufacturing investment tax credits were recognized. The company signed a Direct Funding Agreement for $7.9 billion from the CHIPS Act and has received $2.2 billion in cash to date.

Cash Flow Quality

Operating cash flow improved to $2.86 billion in the first six months of 2025 from $1.07 billion a year ago, despite a larger net loss. The improvement was driven by favorable working capital changes, including a $1.0 billion decrease in accounts receivable and a $1.0 billion increase in accrued compensation. Adjustments for non-cash items (depreciation $5.2B, share-based compensation $1.3B, restructuring charges $382M) added back substantially. Investing activities consumed $2.0 billion (down from $11.7 billion), as capital expenditures fell to $8.7 billion from $11.7 billion and divestiture proceeds provided $1.9 billion from the NAND memory business closing. Financing activities provided $586 million (versus $14.9 billion a year ago), reflecting lower partner contributions and no dividend payments. The company expects to receive approximately $4.4 billion in net cash from the Altera sale in the second half of 2025, with an additional $1.0 billion in deferred consideration.

MD&A / Forward View

Management announced the 2025 Restructuring Plan in Q2, aiming to lower expenses, streamline the organizational structure, and reduce headcount by 15% by year-end 2025. The plan is expected to be substantially complete by Q4 2025, with total charges of approximately $1.9 billion. Concurrently, the company implemented a more disciplined capital deployment approach, stating that future node development (including Intel 14A) requires a clear path to an acceptable return. If a significant external customer for Intel 14A is not secured, the company may pause or discontinue development of leading-edge nodes beyond Intel 18A and Intel 18A-P, retaining the option to use external foundries for future products. This shift could result in significant asset impairments and risks to the company's competitive position.

In terms of strategic transactions, Intel signed an agreement to sell 51% of Altera to Silver Lake for net cash proceeds of approximately $4.4 billion (expected to close in H2 2025) and closed the NAND memory business sale in March 2025, receiving $1.9 billion. Additionally, in July 2025, Intel sold Mobileye shares for net proceeds of $922 million. Government incentives remain a key liquidity source, though recent US government actions create uncertainty about future CHIPS Act disbursements.

Notes & Operating Detail

  • Restructuring: The 2025 Restructuring Plan accrued $1.35 billion as of June 28, 2025, primarily employee severance (cash-settled in future periods). The 2024 Restructuring Plan is substantially complete with $80 million remaining in accruals.
  • Government incentives: $890 million in CHIPS Act grants recognized in H1 2025 ($742M capital-related reducing PP&E, $148M operating benefit in cost of sales). $759 million advanced manufacturing investment tax credit recognized.
  • Equity investments: Net gains of $502 million in Q2 2025 included $469 million in upward observable price adjustments on non-marketable investments, of which $396 million related to a single investee. Marketable equity investments recorded $58 million in unrealized losses.
  • Legal contingencies: Accruals of $1.0 billion for VLSI litigation and $401 million for an EC-imposed fine. A securities class action was dismissed in July 2025.
  • Share-based compensation: $664 million in Q2 2025, down from $780 million a year ago, reflecting lower headcount.
  • Derivatives: Notional amount of outstanding derivatives totaled $38.8 billion at quarter-end. Fair value hedges on debt had cumulative basis adjustments of $335 million.
  • Subsequent events: In July 2025, Intel converted 113.7 million Mobileye Class B shares into Class A and sold 57.5 million shares for $922 million in net proceeds.